Mechnikov Nicaragua Turnkey Pharmaceutical Project

A vaccine manufacturing facility in Nicaragua was in trouble. Mechnikov S.A. asked Fabtech Technologies Ltd to step in. We commissioned the entire project to scope.

We reply within 24 hours.

A glass fronted building corner with large company lettering along the top edge under a cloudy sky

What Mechnikov set out to build

Mechnikov S.A. set out to build a vaccine manufacturing facility in Nicaragua.

The goal was a production facility with an area of 9000 sqm. It would make immunologicals, in particular vaccines to prevent influenza, for the LATAM region.

LATAM means Latin America. Immunologicals are medicines that act on the body's immune system.

Mechnikov wanted a showcase facility for vaccine manufacturing. When completed, it was to be one of the most advanced facilities in the LATAM region and in the world.

Phase 1 of the project included an R&D facility and a vaccine manufacturing unit. R&D means research and development.

A laboratory room with a stainless steel machine with a touch screen, blue benches and a glossy floor

Key fact Detail

Client
Mechnikov S.A., Nicaragua
Kind of facility
Vaccine manufacturing
Planned area
9000 sqm production facility
Phase 1
An R&D facility and a vaccine manufacturing unit
Planned output
Up to 30 million doses of the vaccine a year

Why Mechnikov asked Fabtech to step in

The project was in deep trouble.

A long corridor with white walls, blue doors, ceiling lights and a glossy floor

Another contractor was commissioning it, and that contractor was failing. Commissioning means starting each system and checking that it runs.

The project had many important stakeholders. Stakeholders are the people and organisations that depend on a project.

For them, the project could not be allowed to fail. So the Mechnikov leadership contacted Fabtech and asked us to step in.

What Fabtech did

A plant room full of silver and white pipework, valves and ceiling ducts, with white buckets on the floor

We sent in our projects planning, execution and management team.

We commissioned the entire project to scope. "To scope" means that the team commissioned everything in the agreed scope of work.

The Chief Executive Officer of Mechnikov describes the work in his statement below. He says that Fabtech analysed the project and delivered it.

He also says that we made several technical improvements, and that these made the facility more efficient.

Mechnikov was a turnkey project. In a turnkey project, one company designs, supplies, installs and tests the plant under one contract.

Our page on turnkey pharmaceutical projects explains the stages.

A vaccine plant is a biopharma plant. Biopharma medicines are made from living cells.

Our biopharma solutions page describes what Fabtech does for plants of this kind.

Where the project stood when this case study was written

A large dim hall with a dark floor, blue walls, tall white units and electrical cabinets at the back

When Fabtech wrote this case study, the facility was undergoing validation.

Validation is the written testing that proves the plant works as designed. Our page on equipment qualification explains how this testing is done.

Full scale production was planned to start by September. After that, the facility would be able to produce up to 30 million doses of the vaccine each year.

Mechnikov S.A. planned to produce important vaccines for the diseases that are common among people in Latin America. Together, Mechnikov and Fabtech are helping to save lives.

Affordable medicines become available to the people who need them.

What Mechnikov said

We started our cooperation in a relatively unpleasant time for my company because our main contractor at that time didn't manage to deliver the project on time and to full scope. Fabtech had the will, resources and capabilities to analyse a highly sophisticated pharmaceutical project and to deliver it including implementation of several improvements from a technical point of view that allowed us to create an even more efficient and state-of-the-art facility.

I believe that great companies, especially those working in the sphere of healthcare, bear vast responsibilities to nations and people. Our common aspiration is to deliver best solutions, production practices and products to enhance the level of life. These are the values that Fabtech shares with my company. I have an explicit belief in our long-term relationship and cooperation for the best of quality of life of all nations around the world.

Stanislav Uiba, CEO, Mechnikov S.A., Nicaragua

FAQ

Who completed the Mechnikov vaccine facility in Nicaragua?

Fabtech. Another contractor could not finish the project, so the Mechnikov leadership asked Fabtech to step in. We sent in our projects planning, execution and management team. We commissioned the entire project to scope.

What was the Mechnikov facility planned to make?

Immunologicals, in particular vaccines to prevent influenza, for the LATAM region. LATAM means Latin America. The facility was planned to produce up to 30 million doses of the vaccine each year.

How large is the Mechnikov facility?

The goal was a production facility with an area of 9000 sqm. Phase 1 of the project included an R&D facility and a vaccine manufacturing unit.

Can Fabtech take over a project that another contractor could not finish?

Yes. Mechnikov in Nicaragua is one example. Fidson Healthcare in Nigeria is another. That project had stopped, and Fabtech took it over and commissioned it.

How do I start a vaccine plant project with Fabtech?

Tell us what you want to make, how much, and in which country. Use the contact form on this website. We reply within 24 hours.

Tell us about the vaccine or biopharma plant you plan

We reply within 24 hours.